~~<i id='293BFE5D83'><strike id='293BFE5D83'><tt id='293BFE5D83'><pre id='293BFE5D83'></pre></tt></strike></i>~~

Home» leisure time» entertainment

entertainment

author：knowledge 2025-10-04 05:37:12 Page View：7

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Teladoc has a new CEO, but challenges remain the same
Next article： Affirmative action in medical school literally saved lives

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Pharma companies must ensure equitable access to obesity drugs

TheobesitydrugWegovyisseenatapharmacyinChicago.ScottOlson/GettyImagesWeightlosstreatmentshavethepote

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

1:03Russia'sDefenseMinistry'sfootageofjointnavaldrillswithChinaintheBeringSea,sharedonAug.4,2023.Rus

WSS

entertainment

entertainment

explore

leisure time

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say